Vol. 5, Issue 12, Part F (2019)

Introduction: Diabetic dyslipidemia is characterized by high triglyceride levels and decreased high-density lipoprotein (HDL) cholesterol, changes observed many years before the onset of clinically relevant hyperglycemia. In the world about 382 million people are the victim of hyperglycemia. According to International Diabetes Federation (IDF) estimates in 2013, 35 countries have about 12% prevalence of diabetes. 10–19% of Asian population is currently affected due to diabetes. The prevalence of dyslipidemia in type 2 diabetes is double with respect to the general population.

Methodology: The present study was done in 300 patients. All the patients were aware of the study protocol and form consent to the study.

Results: Of 300 diabetic patients, 180 were hyperlipidemic. Of 180 Diabetic dyslipidemia patients 92 were male and 88 were female. It was higher in male (51.1%) than female (48.8%).

Conclusion: Majority of type 2 diabetic patients are dyslipidemic. The most prevalent pattern among both male and female diabetic patients was high levels of LDL, Triglycerides and low levels of HDL. Clinical pharmacist plays a vital role in counseling the patients about the disease and life style modifications to be followed.